Natick

Hopkinton-based EMC Corp. announced Tuesday it has acquired cloud storage company TwinStrata of Natick for an undisclosed amount.

Karyopharm Therapeutics, the Natick-based biotechnology startup that's developing new cancer treatments for people and animals, is relocating its corporate headquarters to Newton. The company, which launched a successful IPO in the fall, will leave Natick at the end of July and will not have a significant presence in Natick following the move, according to Paul Brannelly, senior vice president of finance and administration at Karyopharm.

Natick-based Karyopharm Therapeutics said underwriters have exercised their option to purchase nearly 400,000 additional stock shares, boosting total offering proceeds to $120.9 million.

Karyopharm Therapeutics has launched a public offering of 2.2 million shares of its common stock as it seeks to generate $77 million in capital.

Natick-based Karyopharm Therapeutics, a clinical-stage company that is developing treatments for cancer and other major diseases, said it has initiated a Phase-2 study of its KPT-330 compound, known as Selinexor, in patients with acute myeloid leukemia (AML).

Boston Scientific said last week its surgical treatment of Parkinson's disease has been found to improve motor scores and decrease medication usage.

Karyopharm Therapeutics has received conditional approval from the U.S. Food and Drug Administration for Verdinexor, its oral treatment of canine lymphoma.

The Patrick administration is awarding nearly $14 million in grants to support new building projects for nonprofit arts and cultural organizations, schools, and communities across the state, including 21 in Central Massachusetts.

Outdoor retailer L.L. Bean will be reopening its Natick Mall pop-up shop June 30, the company announced Tuesday.

Natick-based MathWorks said its MATLAB data analysis program has been selected for use by thousands of researchers at all of Sweden's universities.